Benzodiazepine use and risk of dementia: Evidence from the Caerphilly Prospective Study (caps)

Journal of Epidemiology and Community Health

Volumn 66, Issue 10, 2012, Pages 869-873

  Gallacher, John ^a   Elwood, Peter ^a   Pickering, Janet ^a   Bayer, Antony ^a   Fish, Mark ^b   Ben Shlomo, Yoav ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

AGING POPULATION; COHORT ANALYSIS; DISEASE INCIDENCE; DOSE-RESPONSE RELATIONSHIP; DRUG; ELDERLY POPULATION; HEALTH RISK; INTEGRATED APPROACH; MENTAL HEALTH; PSYCHOLOGY; RISK FACTOR;

AGED; AGING; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITION; CONFIDENCE INTERVAL; DEMENTIA; DRUG EFFECT; FOLLOW UP; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; AGING; BENZODIAZEPINES; COGNITION; CONFIDENCE INTERVALS; DEMENTIA; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WALES;

CAERPHILLY; UNITED KINGDOM; WALES;

EID: 84866044200     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2011-200314     Document Type: Article

References (31)

1. Puustinen J, Nurminen J, Kukola M, et al. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly. Drugs Aging 2007;24: 1045-59.
2. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002;22: 285-93.
3. Hansard. 16 June 2009;494(92): 28WH.
4. Dealberto MJ, Mcavay GJ, Seeman T, et al. Psychotropic drug use and cognitive decline among older men and women. Int J Geriatr Psychiatry 1997;12: 567-74.
5. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998;64: 684-92.
6. Allard J, Artero S, Ritchie K. Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry 2003;18: 874-8.
7. Fastbom J, Forsell Y, Winblad B. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord 1998;12: 14-17.
8. Lagnaoui R, Tournier M, Moride Y, et al. The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age Ageing 2009;38: 226-8.
9. Lagnaoui R, Begaud B, Moore N, et al. Benzodiazepine use and risk of dementia: a nested case-control study. J Clin Epidemiol 2002;55: 314-18.
10. Wu CS, Wang SC, Chang IS, et al. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 2009;17: 614-20.
11. Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005;35: 307-15.
12. Larson EB, Kukull WA, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987;107: 169-73.
13. Barker MJ, Greenwood KM, Jackson M, et al. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004;19: 437-54.
14. Gallacher JE, Elwood PC, Hopkinson C, et al. Cognitive function in the Caerphilly study: associations with age social class, education and mood. Eur J Epidemiol 1999;15: 161-9.
15. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979;9: 139-45.
16. Spielberger CD, Gorsuch RL, Lushene RE. State-Trait Anxiety Inventory Manual. Consulting Psychologists Press. Palo Alto,1970.
17. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993;103: 30-6.
18. Fish M, Bayer A, Gallacher J, et al. Prevalence and pattern of cognitive impairment in a community cohort of men in South Wales: Methodology and findings from the Caerphilly Prospective Study. Neuroepidemiology 2008;30: 25-33.
19. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149: 698-709.
20. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7: 486-8.
21. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55: 1621-6.
22. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull 1988;24: 637-9.
23. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19: 1015-22.
24. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-60.
25. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington DC: American Psychiatric Association, 1994.
26. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-44.
27. Shimohama S, Taniguchi T, Fujiwara M, et al. Changes in benzodiazepine receptors in Alzheimer-type dementia. Ann Neurol 1988;23: 404-6.
28. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357: 169-75.
29. Elwood PC, Bayer AJ, Fish M, et al. Sleep disturbance and daytime sleepiness predict vascular dementia. J Epidemiol Community Health 2011;65: 820-4.
30. Gallacher J, Bayer A, Lowe G, et al. Is sticky blood bad for the brain? hemostatic and inflammatory systems and dementia in the caerphilly prospective study. Arterioscler Thromb Vasc Biol 2010;30: 599-604.
31. Gallacher J, Bayer A, Fish M, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 2009;71: 659-66.